Arrowhead Pharmaceuticals, Inc. (ARWR)
64.19
-0.60
(-0.93%)
USD |
NASDAQ |
Oct 02, 16:00
64.06
-0.13
(-0.20%)
After-Hours: 20:00
Arrowhead Pharmaceuticals Max Drawdown (5Y) : 88.96% for Sept. 30, 2026
Max Drawdown (5Y) Chart
Historical Max Drawdown (5Y) Data
| Date | Value |
|---|---|
| September 30, 2026 | 88.96% |
| August 31, 2026 | 88.96% |
| July 31, 2026 | 88.96% |
| June 30, 2026 | 88.96% |
| May 31, 2026 | 88.96% |
| April 30, 2026 | 88.96% |
| March 31, 2026 | 88.96% |
| February 28, 2026 | 88.96% |
| January 31, 2026 | 88.96% |
| December 31, 2025 | 88.96% |
| November 30, 2025 | 88.96% |
| October 31, 2025 | 88.96% |
| September 30, 2025 | 88.96% |
| August 31, 2025 | 88.96% |
| July 31, 2025 | 88.96% |
| June 30, 2025 | 88.96% |
| May 31, 2025 | 88.96% |
| April 30, 2025 | 88.96% |
| March 31, 2025 | 85.92% |
| February 28, 2025 | 80.44% |
| January 31, 2025 | 80.44% |
| December 31, 2024 | 80.44% |
| November 30, 2024 | 80.44% |
| October 31, 2024 | 80.44% |
| September 30, 2024 | 78.59% |
| Date | Value |
|---|---|
| August 31, 2024 | 76.57% |
| July 31, 2024 | 76.57% |
| June 30, 2024 | 76.57% |
| May 31, 2024 | 76.57% |
| April 30, 2024 | 76.57% |
| March 31, 2024 | 76.57% |
| February 29, 2024 | 76.57% |
| January 31, 2024 | 76.57% |
| December 31, 2023 | 76.57% |
| November 30, 2023 | 76.57% |
| October 31, 2023 | 74.33% |
| September 30, 2023 | 73.83% |
| August 31, 2023 | 73.83% |
| July 31, 2023 | 73.83% |
| June 30, 2023 | 73.83% |
| May 31, 2023 | 73.83% |
| April 30, 2023 | 75.84% |
| March 31, 2023 | 76.03% |
| February 28, 2023 | 76.03% |
| January 31, 2023 | 80.58% |
| December 31, 2022 | 86.00% |
| November 30, 2022 | 88.18% |
| October 31, 2022 | 88.18% |
| September 30, 2022 | 88.18% |
| August 31, 2022 | 89.50% |
Max Drawdown Definition
Max drawdown is an indicator of the risk of a portfolio chosen based on a certain strategy. It measures the largest single drop from peak to bottom in the value of a portfolio before a new peak is achieved.
Max Drawdown (5Y) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Max Drawdown (5Y) Benchmarks
| Sarepta Therapeutics, Inc. | 93.33% |
| Moderna, Inc. | 95.38% |
| Revolution Medicines, Inc. | 73.29% |
| Intellia Therapeutics, Inc. | 96.45% |
| Denali Therapeutics, Inc. | 87.74% |
Max Drawdown (5Y) Related Metrics
| Alpha (5Y) | -15.80 |
| Beta (5Y) | 1.295 |
| Annualized Standard Deviation of Monthly Returns (5Y Lookback) | 69.37% |
| Historical Sharpe Ratio (5Y) | -0.0409 |
| Historical Sortino (5Y) | -0.0988 |
| Monthly Value at Risk (VaR) 5% (5Y Lookback) | 24.07% |